Welcome to another of our Eberhard F. Mammen award announcements. As noted previously,[1 ]
[2 ]
[3 ] Thieme, the publisher of Seminars in Thrombosis & Hemostasis , has created the “Eberhard F. Mammen Excellence in Thrombosis and Hemostasis Awards ” in honor of Eberhard Mammen ([Fig. 1 ]), and in recognition of his contribution to this field and to the journal that he
both founded and steered for over three decades. These awards began in 2009, under
two categories; the current award details and conditions are as follows:
Fig. 1 Eberhard F. Mammen (1930–2008).
Seminars in Thrombosis & Hemostasis . The awards are determined by the Editor in Chief on the basis of user statistics
from Thieme e-Journals from the preceding 2 years. Prefaces, Errata, Letters to the
Editor, and Editorials, and previous award winning articles, are excluded from further
consideration of these awards, which currently comprise two categories—one for “Open
Access” articles, and another for a “General Category.” There are two major cash prizes
of US$1,000 for each category. In addition, winners of the “General Category” awards
are granted “open access” status for these articles thereafter.
Seminars in Thrombosis & Hemostasis . After nominations are received, the awardees are selected by a vote of the Senior
Editors of Seminars in Thrombosis & Hemostasis . Any potential conflicts of interest are managed by first identifying these, and
excluding those with potential conflicts from voting.
Further details of the awards and the award winners are posted online (<https://www.thieme-connect.com/products/ejournals/journal/10.1055/s-00000077 >), and previous award winner announcements are also available in print.[4 ]
[5 ]
[6 ]
[7 ]
[8 ]
[9 ]
[10 ]
[11 ]
[12 ]
[13 ]
[14 ]
[15 ]
[16 ]
The winners of the 2017 Eberhard F. Mammen awards for the most popular articles from
Seminars in Thrombosis & Hemostasis for the period of 2015 to 2016 inclusive were announced in an earlier issue.[16 ] It is therefore with great pleasure that we would like to announce the winners of
the latest round of Young Investigator awards.
As mentioned above, the Young Investigator awards represent winners of the best presentation
or meeting abstract by a young investigator—as presented or delivered to an international
or large regional meeting on a topic related to the fields of thrombosis and hemostasis,
and whose subject matter is determined to be in the spirit of Dr. Mammen. There are
additional considerations given that the nominees' presentations are not always seen
by all of the possible award nominators, being drawn from the editorial team of the
journal. The latest winners are identified below and also listed in [Table 1 ]. The latest awardees were all derived from the latest ISTH 2017 meeting, held in
Berlin in July, 2017. Due to personal conflicts of interest in relation to award nominees,
I excluded myself from voting on this occasion.
Table 1
Latest young investigator awardees
Awardee
Current placement
Presentations awarded
Laura Franco
Internal Medicine, University of Perugia, Italy
Mortality in Patients with Intracerebral Hemorrhage Associated with Vitamin K Antagonists,
Direct Oral Anticoagulants, Antiplatelets or No Antithrombotic Therapy
Elodie Laridan
Cardiovascular Sciences, Kulak, Belgium
Neutrophil Extracellular Traps in Thrombi from Patients with Acute Ischemic Stroke
Leonardo Pasalic
Haematology, Institute of Clinical Pathology and Medical Research, New South Wales
Health Pathology, Australia
Patients with Coronary Artery Disease Have a Pathological P2Y12 Platelet Response
with Heightened Procoagulant Platelet Potential
Yvonne Brennan
Clinical Haematology, Westmead Hospital, Australia
Dental Extractions on NOACs without Stopping Therapy (DENTST) Study
Georgia McCaughan
Australian Red Cross Blood Service, Sydney, Australia
Choice of Anticoagulation in the Obese
Laura Franco ([Fig. 2 ]) is a clinical research fellow at the Internal Medicine Department of University
of Perugia, Italy. She received her degree in Medicine in 2010 at the School of Medicine
of the University of Perugia, Italy. She completed a residency in Emergency Medicine
and has worked in the internal medicine ward at the Vascular and Emergency Medicine–Stroke
Unit Institute, University of Perugia, Italy. Her main interests are hemorrhagic complications
associated with anticoagulant therapy and she is involved in national and international
research projects in the field of anticoagulant treatment.
Fig. 2 Young Investigator Award winner Laura Franco.
Elodie Laridan ([Fig. 3 ]) is currently a PhD student at the Laboratory for Thrombosis Research, Kortrijk,
Belgium. After her graduation in 2013 from the University of Leuven in Belgium as
a biomedical scientist, she first worked as a clinical assistant at the university
hospital in Leuven for a year. Her combined interests for basic and clinical research
made her join the laboratory in Kortrijk in a project focused on neutrophil extracellular
traps and their involvement in ischemic stroke.
Fig. 3 Young Investigator Award winner Elodie Laridan.
Leonardo Pasalic ([Fig. 4 ]) is a hematopathologist and clinical hematologist, currently placed at the Institute
for Clinical Pathology and Medical Research, NSW Health Pathology, Westmead Hospital,
Sydney, Australia. He received his MD in 2004 from the University of New South Wales
(UNSW), Australia. He then completed internal medicine and dual laboratory and clinical
hematology training at Westmead Hospital. He received his PhD from the Faculty of
Medicine, UNSW, Australia, in 2016, for which he investigated various laboratory assays
for characterization of procoagulant platelets and their role in immunothrombosis.
His current clinical focus is on venous thromboembolism and anticoagulants, as well
as bleeding disorders. He has continued to pursue his interests in assay development
in the field of hemostasis and thrombosis, with particular interest in use of flow
cytometry for evaluation of platelet-based biomarkers in clinical diagnostics and
translational research.
Fig. 4 Young Investigator Award winner Leonardo Pasalic.
Yvonne Brennan ([Fig. 5 ]) obtained her medical degree from The University of Sydney in 2006, before completing
residency and basic physicians training at various tertiary hospitals in Sydney. She
is currently in her final year of hematology training with the Royal Australasian
College of Physicians (RACP) and the Royal College of Pathologists of Australasia
(RCPA). Dr. Brennan is also currently a thrombosis and hemostasis fellow at Westmead
Hospital, where she has an outstanding opportunity to pursue her areas of interests,
including thrombosis, hemostasis, and obstetric hematology.
Fig. 5 Young Investigator Award winner Yvonne Brennan.
Georgia McCaughan ([Fig. 6 ]) is a joint RCPA/RACP Haematology Registrar, currently completing a rotation in
Transfusion Medicine at the Australian Red Cross Blood Service in Sydney. She received
her Bachelor of Medicine/Bachelor of Surgery from the University of Sydney in 2011,
graduating with the University Medal. Her current research aims to elucidate the most
appropriate anticoagulation strategy in the obese, and she is setting up an Australian
and New Zealand prospective registry to examine anticoagulant prescribing patterns,
drug-specific levels, and clinical outcomes in this patient group. She is also interested
in the diagnostic approach to heparin-induced thrombocytopenia (HIT), in particular
the availability of rapid diagnostic assays to assist in clinical decision making.
Georgia is a Clinical Associate Lecturer with Sydney Medical School and is actively
engaged in medical student teaching.
Fig. 6 Young Investigator Award winner Georgia McCaughan.
All award winners were elated to hear that they had been selected to receive an Eberhard
F. Mammen Young Investigator award, and provided the following additional commentary:
“I am honored to be a recipient of the 2017 Eberhard F. Mammen Young Investigator
Award. My presentation was on Mortality in Patients with Intracerebral Haemorrhage
Associated with Vitamin K Antagonists, Direct Oral Anticoagulants, Antiplatelets or
No Antithrombotic Therapy. I sincerely thank the Award Committee as well as my supervisors
Drs. Giancarlo Agnelli, Cecilia Becattini, and Maurizio Paciaroni, and all colleagues
who have supported me with my research.”
- Laura Franco ([Fig. 2 ])
“I am very honored to have received an Eberhard F. Mammen Young Investigator Award.
I deeply appreciate the recognition for my project. This award acknowledges a team
effort and the hard work that has been put into the project. Therefore, I would like
to thank Prof. De Meyer and my colleagues from the Laboratory for Thrombosis Research
for having given me the opportunity to be part of this new research angle to investigate
treatments for ischemic stroke.”
- Elodie Laridan ([Fig. 3 ])
“I am incredibly honored to have been selected to receive an Eberhard F. Mammen Young
Investigator Award. This award acknowledges our research investigating the role of
procoagulant platelets in atherothrombotic disorders. This award would not have come
to realisation without a truly collaborative effort and without the contributions
of Drs. Edwina Wing-Lun, Jerrett Lau and Heather Campbell. I would like to take this
opportunity to acknowledge my supervisor Dr. Vivien Chen and all my colleagues at
Lowy Cancer Research Institute (Sydney, Australia) for their ongoing support and contribution
to this work.”
- Leonardo Pasalic ([Fig. 4 ])
“I was thrilled and honored to be a recipient of an Eberhard F. Mammen Young Investigator
Award, and to thus be recorded alongside the impressive list of prior award winners.
I would like to thank my dental collaborators who have made possible the work for
which I was nominated. I feel very fortunate and grateful to have Dr. Jennifer Curnow
as my mentor, and also wish to thank the Editor in Chief of STH, Dr. Emmanuel Favaloro,
another of my mentors, for this opportunity to shine.”
- Yvonne Brennan ([Fig. 5 ])
“I was extremely honored to receive an Eberhard F. Mammen Young Investigator Award.
The project for which I was nominated, and our prospective registry in development,
would not have happened without the support and direction of my supervisors Dr. Helen
Crowther and Dr. Jennifer Curnow. I would also like to thank Dr. Leonardo Pasalic
and Dr. Emmanuel Favaloro for their support and enthusiasm in encouraging me to pursue
research in thrombosis and haemostasis.”
- Georgia McCaughan ([Fig. 6 ])
In keeping with previous editorials, I have again reviewed the Young Investigator
awardees from previous years as well as the outcome of their subsequent submissions[17 ]
[18 ]
[19 ]
[20 ]
[21 ]
[22 ]
[23 ]
[24 ]
[25 ]
[26 ]
[27 ]
[28 ]
[29 ]
[30 ]
[31 ]
[32 ]
[33 ]
[34 ]
[35 ]
[36 ]
[37 ]
[38 ]
[39 ]
[40 ]
[41 ]
[42 ]
[43 ]
[44 ]
[45 ]
[46 ]
[47 ]
[48 ]
[49 ]
[50 ] to Seminars in Thrombosis & Hemostasis , and as summarized in [Table 2 ]. I previously mentioned my personal gratification that most of the papers from earlier
years have subsequently appeared in several annual top 100 listings.[9 ]
[10 ]
[12 ]
[14 ]
[15 ]
[16 ] Of further interest, one of these papers actually won one of the Most Popular awards
in 2014 (within the Open Access Category) based on the “most popular” 2012–2013 list.[22 ] Also motivating is that a few of the Young Investigator awardees were also included
as authors on other contributions to Seminars in Thrombosis & Hemostasis that were also listed in these most popular listings, including another 2014 Most
Popular award winner.[51 ]
Table 2
Young investigator awardees from previous years
Awardee
Year awarded
Publication arising
Willem M. Lijfering
2009
Lijfering WM, Flinterman LE, Vandenbroucke JP, Rosendaal FR, Cannegieter SC. Relationship
between venous and arterial thrombosis: a review of the literature from a causal perspective.
Semin Thromb Hemost 2011;37(8):885–896
Salley Pels
2009
Pels SG. Current therapies in primary immune thrombocytopenia. Semin Thromb Hemost
2011;37(6):621–630
Adam Cuker
2010
Cuker A. Current and emerging therapeutics for heparin-induced thrombocytopenia. Semin
Thromb Hemost 2012;38(1):31–37
Giridhara Rao Jayandharan
2010
Jayandharan GR, Srivastava A, Srivastava A. Role of molecular genetics in hemophilia:
from diagnosis to therapy. Semin Thromb Hemost 2012;38(1):64–78
Timea Szanto
2010
Szántó T, Joutsi-Korhonen L, Deckmyn H, Lassila R. New insights into von Willebrand
disease and platelet function. Semin Thromb Hemost 2012;38(1):55–63
Birgitta Salmela
2010
Salmela B, Joutsi-Korhonen L, Armstrong E, Lassila R. Active online assessment of
patients using new oral anticoagulants: bleeding risk, compliance, and coagulation
analysis. Semin Thromb Hemost 2012;38(1):23–30
Pia Riittaa-Maria Siljander
2010
Aatonen M, Grönholm M, Siljander PR. Platelet-derived microvesicles: multitalented
participants in intercellular communication. Semin Thromb Hemost 2012;38(1):102–113.
Romaric Lacroix
2011
Lacroix R, Dignat-George F. Microparticles: new protagonists in pericellular and intravascular
proteolysis. Semin Thromb Hemost 2013;39(1):33–39
Brad McEwen
2011
McEwen BJ, Morel-Kopp MC, Chen W, Tofler GH, Ward CM. Effects of omega-3 polyunsaturated
fatty acids on platelet function in healthy subjects and subjects with cardiovascular
disease. Semin Thromb Hemost 2013;39(1):25–32
Neil A. Goldenberg
2011
Bernard TJ, Armstrong-Wells J, Goldenberg NA. The institution-based prospective inception
cohort study: design, implementation, and quality assurance in pediatric thrombosis
and stroke research. Semin Thromb Hemost 2013;39(1):10–14
Vivien Chen
2011
Chen VM. Tissue factor de-encryption, thrombus formation, and thiol-disulfide exchange.
Semin Thromb Hemost 2013;39(1):40–47
Joseph E. Italiano, Jr.
2011
Italiano JE Jr. Unraveling mechanisms that control platelet production. Semin Thromb
Hemost 2013;39(1):15–24
Vivian Xiaoyan Du
2012/2013
Du VX, Huskens D, Maas C, Al Dieri R, de Groot PG, de Laat B. New insights into the
role of erythrocytes in thrombus formation. Semin Thromb Hemost 2014;40(1):72–80
Andrew Yee
2012/2013
Yee A, Kretz CA. Von Willebrand factor: form for function. Semin Thromb Hemost 2014;40(1):17–27
Sarah O'Brien
2012/2013
O'Brien SH. Contraception-related venous thromboembolism in adolescents. Semin Thromb
Hemost 2014;40(1):66–71
Veronica Flood
2012/2013
Flood VH. Perils, problems, and progress in laboratory diagnosis of von Willebrand
disease. Semin Thromb Hemost 2014;40(1):41–48
Julie Tange
2012/2013
Tange JI, Grill D, Koch CD, et al. Local verification and assignment of mean normal
prothrombin time and International Sensitivity Index values across various instruments:
recent experience and outcome from North America. Semin Thromb Hemost 2014;40(1):115–120
Kent Chapman
2012/2013
Chapman K, Yuen S. Therapy for thrombotic thrombocytopenia purpura: past, present,
and future. Semin Thromb Hemost 2014;40(1):34–40
Andreas Tiede
2014
Tiede A, Werwitzke S, Scharf RE. Laboratory diagnosis of acquired hemophilia a: limitations,
consequences, and challenges. Semin Thromb Hemost 2014;40(7):803–811
Wendy Lim
2014
Lim W. Thrombotic risk in the antiphospholipid syndrome. Semin Thromb Hemost 2014;40(7):741–746
Susana Nobre Fernandes
2014
Fernandes S, Carvalho M, Lopes M, Araújo F. Impact of an individualized prophylaxis
approach on young adults with severe hemophilia. Semin Thromb Hemost 2014;40(7):785–789
Maria Elisa Mancuso
2014
Mancuso ME, Fasulo MR. Thrombin generation assay as a laboratory monitoring tool during
by-passing therapy in patients with hemophilia and inhibitors. Semin Thromb Hemost
2016;42(1):30–35
Coen Maas
2014
Tersteeg C, Fijnheer R, Deforche L, et al. Keeping von Willebrand factor under control:
alternatives for ADAMTS13. Semin Thromb Hemost 2016;42(1):9–17
Riten Kumar
2014
Kumar R, Dunn A, Carcao M. Changing paradigm of hemophilia management: extended half-life
factor concentrates and gene therapy. Semin Thromb Hemost 2016;42(1):18–29
Juraj Sokol
2015
Sokol J, Skerenova M, Jedinakova Z, et al. Progress in the understanding of sticky
platelet syndrome. Semin Thromb Hemost 2017;43(1):8–13
Ljubica Jovanović
2015
Jovanovic L, Antonijevic N, Novakovic T, et al. Practical aspects of monitoring of
antiplatelet therapy. Semin Thromb Hemost 2017;43(1):14–23
Lucia Stanciakova
2015
Stanciakova L, Dobrotova M, Jedinakova Z, et al. Monitoring of hemostasis and management
of anticoagulant thromboprophylaxis in pregnant women with increased risk of fetal
loss. Semin Thromb Hemost 2016;42(6):612–621
Tina Biss
2015
Biss TT. Venous thromboembolism in children: is it preventable? Semin Thromb Hemost
2016;42(6):603–611
Tobias Fuchs
2015
Jiménez-Alcázar M, Kim N, Fuchs TA. Circulating extracellular DNA: cause or consequence
of thrombosis? Semin Thromb Hemost 2017;43(6):553–561
Jonathan M. Coutinho
2015
Silvis SM, Middeldorp S, Zuurbier SM, Cannegieter SC, Coutinho JM. Risk factors for
cerebral venous thrombosis. Semin Thromb Hemost 2016;42(6):622–631
Soundarya Selvam
2016
Selvam S, James P. Angiodysplasia in von Willebrand disease: understanding the clinical
and basic science. Semin Thromb Hemost 2017;43(6):572–580
Vincent Muczynski
2016
Muczynski V, Christophe OD, Denis CV, Lenting PJ. Emerging therapeutic strategies
in the treatment of hemophilia A. Semin Thromb Hemost 2017;43(6):581–590
Karen Schreiber
2016
Schreiber K, Breen K, Cohen H, et al. HYdroxychloroquine to improve pregnancy outcome
in women with AnTIphospholipid Antibodies (HYPATIA) Protocol: a multinational randomized
controlled trial of hydroxychloroquine versus placebo in addition to standard treatment
in pregnant women with antiphospholipid syndrome or antibodies. Semin Thromb Hemost
2017;43(6):562–571
Jasmine Wee Ting Tay
2016
Tay J, Tiao J, Hughes Q, Jorritsma J, Gilmore G, Baker R. Circulating microRNA as
thrombosis sentinels: caveats and considerations. Semin Thromb Hemost 2018. doi: 10.1055/s-0037-1606568
Adi J. Klil-Drori
2016
Klil-Drori AJ, Tagalakis V. Direct oral anticoagulants in end-stage renal disease.
Semin Thromb Hemost 2018. DOI: https://doi.org/10.1055/s-0037-1621715 .
Lindsey A. George
2016
Submission still pending
Ivar van Asten
2017
van Asten I, Schutgens REG, Urbanus RT. Towards flow cytometry based platelet function
diagnostics. Semin Thromb Hemost 2018.
These findings act to validate the Young Investigator award process, and I look forward
to seeing their careers continue to develop. These findings also suggest that future
Young Investigator awardees have very high bars established, and I wish them the best
of luck to exceed the precedence set by earlier awardees.
I would like as always to congratulate the current Young Investigator awardees for
their awards, and will also take the opportunity to thank previous Young Investigator
awardees for their contributions; these have obviously been well received by readers
of this journal. I look forward to reading, and monitoring the future popularity,
of the contributions from the latest group of Young Investigators!
